Search
for
Sort by
Research 361–390 of 1000+
- Serum brain‐derived neurotrophic factor and vitamin D: Two concordant players controlling depression among alopecia areata and vitiligo patients: A case–control study
- Clinical manifestations of alopecia in autoimmune blistering diseases: A cross-sectional study
- Trichoscopic signs in systemic lupus erythematosus: a comparative study with 109 patients and 305 healthy controls
- The Adapted Classification of Male Pattern Hair Loss Improves Reliability
- Association of resilience and perceived stress in patients with alopecia areata: A cross-sectional study
- Standardized classification tools in dermatology: time to focus on cutaneous warts
- Quality-of-Life Assessment in Singaporean Children with Alopecia Areata
- British Association of Dermatologists living guideline for managing people with alopecia areata 2024
- Taiwanese Dermatological Association consensus on the diagnosis and management of alopecia areata
- Comparison of Current International Guidelines for the Management of Alopecia Areata—Comprehensive Review
- Adult patients with alopecia areata report a significantly better medication adherence compared to those with atopic dermatitis: Results from a large cross-sectional cohort study
- Enhancing Quality of Life and Sexual Functioning in Female Androgenetic Alopecia: Therapeutic Potential of Hair Follicle-Derived Stem Cells
- Validation of an Egyptian Arabic Version of Skindex-16 and Quality of Life Measurement in Egyptian Patients with Skin Disease
- Comparison of Dermatology Life Quality Index Scores in Adults and Adolescents with Alopecia Areata
- Korean Consensus Criteria for the Severity Classification of Alopecia Areata
- Survey on Alopecia Areata Patients’ Reported Factors that Determine Severity of Alopecia Areata: A Nationwide Multicenter Study
- Post COVID Alopecia in the Indian Subcontinent - A Harbinger of Disease Severity
- ASSESSMENT OF SERUM LEVELS OF ANTIGLIADIN ANTIBODIES (IgG and IgA) IN PATIENTS WITH ALOPECIA AREATA AND THEIR RELATION TO SEVERITY OF THE DISEASE
- ASSESSMENT OF SERUM LEVELS OF ANTIGLIADIN ANTIBODIES (IGG AND IGA) IN PATIENTS WITH ALOPECIA AREATA AND THEIR RELATION TO SEVERITY OF THE DISEASE
- Serum level of interleukin-15 in active alopecia areata patients and its relation to age, sex, and disease severity
- Az alopecia areata kezelésében alkalmazott baricitinib hatásosságának és biztonságosságának retrospektív vizsgálata = Efficacy and safety of baricitinib treatment in alopecia areata:a retrospective analysis
- Tofacitinib for the treatment of alopecia areata and variants in adolescents
- Extensive alopecia areata: Not necessarily recalcitrant to therapy!
- Experience with oral tofacitinib in severe alopecia areata with different clinical responses
- Factors Affecting the Psychosocial Distress of Patients with Alopecia Areata: A Nationwide Study in Korea
- Retrospective Analysis of Systemic Corticosteroids for Alopecia Areata in Pediatric Patients
- Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical Trial
- Efficacy and safety of tofacitinib in patients with alopecia areata
- Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies
- Baricitinib in the Management of Severe Alopecia Areata: A Report of Two Cases With Sustained Clinical Response